Search

Search Constraints

You searched for: Author/Creator Loguercio, C.

Search Results

3. P.09.8: Role of Bisphenol a as Environmental Factor in the Promotion of Non-Alcoholic Fatty Liver Disease: In VITRO and in VIVO Protective Effects of Silybin. (15th March 2017)

4. P.08.8: Silybin in Combination with Regorafenib as a Novel Potential Strategy for the Treatment of Metastatic Colorectal Cancer Patients. (15th March 2017)

5. Role of bisphenol A as environmental factor in the promotion of non‐alcoholic fatty liver disease: in vitro and clinical study. Issue 6 (11th January 2018)

7. T02.01.9 EFFICACY OF 14-DAY CONCOMITANT THERAPY IN THE ERADICATION OF H. PYLORI INFECTION: COMPARISON WITH 10-DAY CONCOMITANT THERAPY. (1st October 2020)

8. T06.01.9 THE BISPHENOL A INDUCED WORSENING OF NON-ALCOHOLIC FATTY LIVER DISEASE: A CLINICAL STRATEGY TO ANTAGONIZE THE PROGRESSION OF THE DISEASE. (1st October 2020)

9. P.10.1 REACTIVATION OF HEPATITIS B VIRUS IN CANCER PATIENTS TREATED WITH CHEMOTHERAPY FOR SOLID TUMORS. IS THE PROPHYLAXIS REALLY REQUIRED?. (24th February 2016)

10. P.10.2 EFFECTS OF SILYBIN ADMINISTRATION ON THE REDOX STATE AND OXIDATIVE STRESS RESPONSE OF HUMAN ENDOTHELIAL CELLS IN PATIENTS WITH NON-ALCOHOLIC STEATOHEPATITIS. (24th February 2016)